Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2025-12-24 @ 5:34 PM
NCT ID:
NCT00950768
Eligibility Criteria:
Inclusion criteria included:
* diagnosis of untreated Durie \& Salmon stage IIA-IIIB measurable multiple myeloma;
* age \< 65 years.
Exclusion criteria included:
* prior treatment for myeloma;
* abnormal cardiac function, defined as systolic ejection fraction \<50%;
* abnormal pulmonary spirometry test;
* serum bilirubins \> 2.5 times normal and ALAT and/or ASAT \> 2 times normal;
* seropositivity for HIV, HCV or HBV, active non-hematologic malignancies.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00950768
Study Brief:
Protocol Section:
NCT00950768